Skip to main content
Premium Trial:

Request an Annual Quote

Arrayjet Inks Contract With NY Bioscience Cluster

NEW YORK (GenomeWeb) – Arrayjet said today that it has secured an approximately $250,000 contract with the New York Bioscience Cluster for microarray instrumentation, printing, and expertise.

The Bronx-based NYBC provides gene expression research services for diseases and disorders related to immunology, cancer, diabetes, and liver function, and will use Arrayjet's Marathon Argus high-throughput bioprinter for much of this work, Edinburgh, Scotland-based Arrayjet said.

In addition, the NYBC will use Arrayjet Advance, an outsourced customized microarray printing service launched by Arrayjet in 2011. This allows NYBC to access application support through Arrayjet, which will perform proof-of-principle studies for protein and DNA printing prior to purchase, the company said.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.